There is a good evidence that inflammation in the breast is an increased risk factor for the development of breast cancer. In fact, all cancers have associated inflammation. A number of factors increase breast inflammation:

  • Benign breast disease, often called fibrocystic disease or breast lumps. BBD increases lifetime risk of

breast cancer by ~30%.

  • Environmental pollutants, called organophosphates, are endocrine disruptors, and accumulate in breast tissue creating local inflammation.
  • Breast implants create chronic inflammation, because they are a foreign material.
  • Obesity increases risk of breast cancer. Obesity produces inflammatory cells, throughout the body and especially in the breasts. Since the breast is mostly fatty tissue, the breast is at increased risk of developing more focused, often strong local inflammation.

PEMFs are well known to decrease chronic inflammation and restore normal tissue. Reducing inflammation lowers the risk of developing breast cancer. So, any woman with any of the above reasons to have chronic breast inflammation should consider PEMF therapy. Women with BBD or breast implants are strongly recommended to consider routine, preferably daily, use of PEMFs either locally or with whole body treatment.

A study about PEMFs and breast cancer

In a 2013 study, the authors studied the potential for ultra-low intensity and frequency PEMFs to kill breast cancer cells. They wanted to see if the PEMFs in question could show: 1) toxicity to breast cancer cells and; 2) and they were not harmful to healthy cells. Breast cancer cells and normal cells were exposed to PEMFs and cell death indices were measured to determine which PEMFs best kill breast cancer cells. The PEMF parameters tested were: 1) frequencies ranging from 20 to 50 Hz; 2) intensities ranging from 2 mT (20 Gauss) to 5 mT (50 Gauss) and; 3) exposure times ranging from 30-90 minutes per day for up to three days. These were to determine the optimum parameters for selective cancer cell killing. At the end of the study they found a discrete optimal window of vulnerability of breast cancer cells to PEMFs of 20 Hz frequency, 3 mT (30 Gauss) magnetic field intensity and exposure duration of 60 minutes per day. PEMFs applied at a repetition rate of 50 Hz did not produce any noticeable effects on cell viability. The amount of cell damage seen in response to PEMFs increased with time and was even more significant after three days of consecutive daily exposures. By contrast, the optimal PEMF usage found to be the most damaging to breast cancer cells was not damaging to normal cells and were in fact slightly enhancing to normal cell function. However, based on the evidence from this study, other exposure times (that is, 90 minutes) and intensities 2 mT and 5 mT) were still very strongly effective for killing breast cancer cells, even though not optimal. That means that 20 Gauss and 50 Gauss PEMFs were also quite effective and both 60 minutes and 90-minute exposures were also effective.